Komori
Alfresa Holdings (2784) · FactFirst stated

FY2021 Revenue and Profit Decline in the Prescription Drug and Other Pharmaceutical Wholesale Business

First written in FY2021. . Latest entry: FY2021.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Lower revenue and earnings in the wholesale business for prescription drugs and other pharmaceuticalsA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021First statedAnnual report

    「当セグメントの当連結会計年度の業績は、薬価改定および新型コロナウイルス感染拡大の影響等による市場のマイナス成長ならびに価格競争の激化等により、売上高2兆2,906億24百万円(前期比3.6％減)、営業利益183億8百万円(同56.1％減)となりました。」

    医療用医薬品等卸売事業は、薬価改定、感染拡大、市場のマイナス成長、価格競争激化等により減収減益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.